Biodexa Pharmaceuticals Plc ADR (BDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -15,441 | -14,965 | N/A |
| Depreciation Amortization | 1,127 | 531 | N/A |
| Accounts receivable | -2,355 | 1,254 | N/A |
| Accounts payable and accrued liabilities | 1,087 | 768 | N/A |
| Other Working Capital | -1,362 | 2,022 | N/A |
| Other Operating Activity | -2,047 | 1,402 | 0 |
| Operating Cash Flow | $-18,992 | $-8,989 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,410 | -1,697 | N/A |
| Net Acquisitions | -1,011 | 190 | N/A |
| Purchase Sale Intangibles | -5 | N/A | N/A |
| Other Investing Activity | 76 | 13 | 0 |
| Investing Cash Flow | $-2,344 | $-1,495 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 1,467 | N/A |
| Debt Repayment | -252 | -570 | N/A |
| Common Stock Issued | N/A | 55,781 | N/A |
| Other Financing Activity | -83 | -158 | 0 |
| Financing Cash Flow | $-335 | $56,520 | $N/A |
| Exchange Rate Effect | 35 | N/A | N/A |
| Beginning Cash Position | 46,367 | 3,933 | N/A |
| End Cash Position | 24,732 | 49,970 | N/A |
| Net Cash Flow | $-21,635 | $46,036 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -18,992 | -8,989 | N/A |
| Capital Expenditure | -1,410 | -1,697 | N/A |
| Free Cash Flow | -20,401 | -10,686 | 0 |